Adherence Packaging Market Analysis & Forecast: 2025-2032

Adherence Packaging Market Size and Trends

Global adherence packaging market is estimated to be valued at USD 1.12 Bn in 2025 and is expected to reach USD 1.81 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.1 from 2025 to 2032.

Discover market dynamics shaping the industry: Request sample copy

Growing geriatric population, increasing prevalence of chronic diseases, and rising need for enhanced medication administration are some of the key factors that are expected to drive the growth of the global adherence packaging market. Adherence packaging aids patients suffering from chronic diseases in properly following medical schedules and instructions. It plays a crucial role in improving patient outcomes by enhancing medication adherence. The demand for user-friendly packaging solutions that make healthcare more accessible is increasing among both patients and healthcare providers globally. This is expected to present lucrative opportunities for adherence packaging manufacturers in the near future.

 Growing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases across the globe is significantly driving the growth of the global adherence packaging market. As per the World Health Organization (WHO), chronic diseases such as cardiovascular diseases, cancer, respiratory diseases and diabetes are estimated to account for over 70% of all deaths globally. Most chronic diseases require patients to follow complicated prescription drug regimens involving multiple medications, some of which need to be taken several times a day. Poor medication adherence is quite common among chronically ill patients and it has been reported that nearly half of patients fail to take medications as prescribed by their healthcare providers. This often leads to disease complications, increased healthcare costs and poor patient outcomes.  This is where adherence packaging plays a crucial role. By packaging medications in dose-wise sachets or blister packs for individual days of the week, adherence packaging helps simplify complicated treatment schedules for patients. This format helps patients easily identify the correct medications at the right time, thereby improving medication adherence. It also allows family members and caregivers to keep a check on whether prescriptions are being properly followed. The individual packaging approach helps pharmacies dispense multi-drug regimens in an organized manner. According to the National Association of State Mental Health Program Directors (NASMHPD), adherence packaging led to 50-70% reduction in medication administration errors in long-term care facilities for people with mental illness.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Ageing populations in developed and developing countries alike have amplified focus on geriatric care needs and related services. According to the data published by United Nations, there were around 703 million persons aged 65 years or over globally in 2019 accounting for nearly 9% of the world's population. This figure is projected to double to 1.5 billion by 2050 meaning 1 in six people will be elderly. Caring for the health and well-being of older adults presents unique challenges and medication adherence is recognized as a key factor influencing outcomes for the aged. However, forgetfulness, confusion, impaired vision or dexterity can hinder proper self-administration of multiple prescriptions among seniors.

To learn more about this report, Request sample copy

Challenge: Rising packaging costs and regulatory issues

Rising packaging costs and regulatory requirements are posing significant challenges for the growth of the global adherence packaging market. Packaging manufacturers are facing increased costs of raw materials like plastic, paper and aluminum used for producing adherence blisters and strip packaging. The prices of oil and plastic resins from which polymers are derived have risen sharply in the past year due to disruption of global supply chains during the pandemic and now due to the ongoing geo-political issues. This has directly translated to higher production costs for adherence packaging.  Additionally, stringent regulatory norms especially in the pharma industry have increased the compliance burden for adherence packaging. Regulators are mandating child resistant packaging and senior friendly designs to prevent accidental misuse. They also requires enhanced tamper evidence features and product theft prevention mechanisms. Compliance to these regulations involved expensive testing and certification process. The packaging designs have become more complex with multilayered materials and advanced sealing technologies to meet the regulations. This has significantly raised the overall R&D and capital investment costs for adherence packaging manufacturers.

Opportunity: Untapped markets in developing countries

Untapped markets in developing countries offer huge potential opportunities for the global adherence packaging market. Regions like Africa, South Asia and parts of Latin America are still in their developmental phases with rising income levels and growing health awareness. As living standards improve gradually in these markets, people are able to afford advanced healthcare and medical solutions which were not priorities or accessible before.  Adherence packaging plays a crucial role in medication management, treatment continuity and overall healthcare outcomes. It helps patients stick to their dosage schedules, take the right medicines on time and complete the course of therapy. This is particularly important for chronic conditions like diabetes, hypertension, asthma etc. which require lifelong treatment adherence. As non-communicable diseases rise worldwide due to lifestyle changes, the needs for adherence solutions will surge substantially. According to World Health Organization, adherence to long-term therapy for chronic illnesses in developing countries averages only 50%. Poor monitoring of drug intake significantly impacts treatment effectiveness and increases risks of complications or re-admissions.

Discover high revenue pocket segments and roadmap to it: Request sample copy

In terms of material, paper and paperboard segment is estimated to contribute the 41.7% market share in 2025, due to its cost effectiveness and sustainable properties. As adherence packaging aims to reduce medication wastage and encourage prescribed dosage routines, the cost of procuring and manufacturing the packaging plays a huge role. Paper and paperboard offers a low-cost solution suitable for high-volume blister and strip packaging. It is arguably the most sustainable material choice, being renewable and biodegradable. This is a key driver of adherence to treatment plans in price-sensitive regions and patient demographics. Paper and paperboard's versatility allows for innovative packaging formats aiding dose administration tracking and compliance. Its cost-to-performance ratio makes it the material of choice for targeting widespread chronic disease management globally.

Insights, By Type: Flexibility and tracking drive multi-dose packaging dominance

In terms of type, multi-dose packaging segment is estimated to contribute the 68.3% market share in 2025, owing to its flexibility and tracking abilities. Multi-dose packs are tailored to patient needs over days, weeks or months. This flexibility addresses variability in dosing schedules and treatment durations more effectively than single-dose packs. Multi-compartment blisters and strip packs with day and time labels empower patients to self-administer accurately. These integrate monitoring functionality, enabling care teams to track intake and intervene proactively. This two-way communication is instrumental in long-term condition management. Multi-dose packaging has transformed from simple blister packs to high-tech track-and-trace platforms, consolidating its dominance in the adherence packaging market.

Insights, By Packaging Type: Ease of use and tamper evidence drive blister dominance

In terms of packaging type, blisters segment is estimated to contribute the 38.3% market share in 2025, owing to their ease of use and tamper evident properties. Individual pre-formed cavities provide robust, leak-proof containment of solid or liquid medicines in tablet, capsule or sachet form. Blister foils can be clearly printed with dosage instructions and labeling which is a user-friendly feature for all ages and capabilities. Once sealed, the lidding material cannot be removed and replaced without visible evidence, assuring content integrity. For patients, blister packs are incredibly simple to operate -  peel back the foil to access each dose in a sequential manner. The push-through nature improves compliance for those with dexterity issues too. Overall, blisters check all the boxes for effective adherence packaging, from production to point-of-care, cementing their prominence.

Regional Insights

Need a Different Region or Segment? Customize now

North America has established itself as the dominant region in the global adherence packaging market over the past few decades with estimated 38.1% share in 2025. The large size and developed nature of the healthcare sector in countries like the U.S. has gone a long way in driving the widespread adoption of adherence packaging solutions. Several pharmaceutical manufacturers in the region have compliance packaging as an integral part of their medication dispensing process.

The Asia Pacific region has emerged as the fastest growing adherence packaging market globally due to increasing healthcare expenditures and growing medical needs of its burgeoning population. Rapid economic development across Asia has raised living standards and healthcare is gaining higher priority. This has boosted the sales and distribution of myriad prescription drugs. Consequently, the need for packaging formats that promote medication adherence is rising among physicians and patients alike. Further augmenting growth is the presence of a conducive business environment and low-cost manufacturing centers which are powering the expansion of both international and local pharmaceutical companies within Asia Pacific. Countries like China and India with their giant population bases and developing pharmaceutical industries have become lucrative markets for adherence packaging solutions. Propelled by the aforementioned factors, Asia Pacific is expected to play a pivotal role in shaping the future dynamics of this market.

Market Report Scope

Market Segmentation

• Material Insights (Revenue, USD Bn & KT, 2020 - 2032)
  • Plastic
    • PV
    • PET
    • PVC
    • PP
  • Paper and Paperboard
  • Aluminum
  • Others
•  Type Insights (Revenue, USD Bn & KT, 2020 - 2032)
  • Unit-dose Blisters
  • Multi-dose Pouches
• Packaging Type Insights (Revenue, USD Bn & KT, 2020 - 2032)
  • Blisters
  • Pouches
  • Others
•  End User Insights (Revenue, USD Bn & KT, 2020 - 2032)
  • Pharmacies
  • Hospitals
  • Other End Users
• Regional Insights (Revenue, USD Bn & KT, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Key Players Insights
  • Westrock Company
  • Keystone Folding Box Co.
  • Cardinal Health Inc.
  • Omnicell Inc.
  • Jones Healthcare Group
  • Drug Package LLC
  • Parata Systems LLC
  • Manrex Limited
  • Medicine-On-Time LLC
  • Rx Systems Inc.
  • AARDEX Group
  • Becton
  • Dickinson and Company
  • Talyst
  • TCGRx
  • McKesson Corporation
  • KUKA AG
  • Pearson Medical Technologies LLC